Leslie E. Martin

939 total citations
17 papers, 758 citations indexed

About

Leslie E. Martin is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Leslie E. Martin has authored 17 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Oncology and 3 papers in Hepatology. Recurrent topics in Leslie E. Martin's work include HER2/EGFR in Cancer Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver physiology and pathology (2 papers). Leslie E. Martin is often cited by papers focused on HER2/EGFR in Cancer Research (4 papers), Drug Transport and Resistance Mechanisms (3 papers) and Liver physiology and pathology (2 papers). Leslie E. Martin collaborates with scholars based in United States, United Kingdom and India. Leslie E. Martin's co-authors include Mark W. Lingen, Ezra E.W. Cohen, Everett E. Vokes, Robert Hopkins, William N. Jenner, Rifat Hasina, Hongyan Zhu, Marsha Rich Rosner, Andres J. Klein–Szanto and Vidya Nallasura and has published in prestigious journals such as Cancer Research, Clinical Cancer Research and The Journal of Pediatrics.

In The Last Decade

Leslie E. Martin

17 papers receiving 703 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Leslie E. Martin United States 13 363 262 196 125 120 17 758
Lizhu Lin China 13 228 0.6× 397 1.5× 239 1.2× 131 1.0× 121 1.0× 47 766
Jen‐Tsun Lin Taiwan 16 306 0.8× 126 0.5× 60 0.3× 96 0.8× 24 0.2× 34 669
Carlos García Girón Spain 20 203 0.6× 680 2.6× 433 2.2× 98 0.8× 119 1.0× 96 1.1k
Toshihiro Abe Japan 16 302 0.8× 303 1.2× 273 1.4× 146 1.2× 26 0.2× 49 956
Feng‐Che Kuan Taiwan 12 146 0.4× 186 0.7× 167 0.9× 112 0.9× 33 0.3× 31 448
E.L. Levine United Kingdom 11 351 1.0× 481 1.8× 169 0.9× 290 2.3× 18 0.1× 17 1.4k
Fion L. Sung Hong Kong 12 312 0.9× 115 0.4× 63 0.3× 122 1.0× 32 0.3× 14 817
Mohan C. Pant India 20 539 1.5× 212 0.8× 139 0.7× 144 1.2× 83 0.7× 40 933
Wenjie Zhou China 14 268 0.7× 187 0.7× 132 0.7× 163 1.3× 9 0.1× 39 629
Feng Shi China 16 120 0.3× 121 0.5× 219 1.1× 87 0.7× 52 0.4× 54 673

Countries citing papers authored by Leslie E. Martin

Since Specialization
Citations

This map shows the geographic impact of Leslie E. Martin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie E. Martin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie E. Martin more than expected).

Fields of papers citing papers by Leslie E. Martin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leslie E. Martin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie E. Martin. The network helps show where Leslie E. Martin may publish in the future.

Co-authorship network of co-authors of Leslie E. Martin

This figure shows the co-authorship network connecting the top 25 collaborators of Leslie E. Martin. A scholar is included among the top collaborators of Leslie E. Martin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leslie E. Martin. Leslie E. Martin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Seiwert, Tanguy Y., Ramasamy Jagadeeswaran, Leonardo Faoro, et al.. (2009). The MET Receptor Tyrosine Kinase Is a Potential Novel Therapeutic Target for Head and Neck Squamous Cell Carcinoma. Cancer Research. 69(7). 3021–3031. 211 indexed citations
2.
Hasina, Rifat, et al.. (2009). ABT-510 Is an Effective Chemopreventive Agent in the Mouse 4-Nitroquinoline 1-Oxide Model of Oral Carcinogenesis. Cancer Prevention Research. 2(4). 385–393. 49 indexed citations
3.
Cohen, Ezra E.W., Hongyan Zhu, Mark W. Lingen, et al.. (2008). A Feed-Forward Loop Involving Protein Kinase Cα and MicroRNAs Regulates Tumor Cell Cycle. Cancer Research. 69(1). 65–74. 67 indexed citations
4.
Radhakrishnan, Raghu, Monica Charlotte Solomon, Kapaettu Satyamoorthy, Leslie E. Martin, & Mark W. Lingen. (2008). Tissue microarray – a high‐throughput molecular analysis in head and neck cancer. Journal of Oral Pathology and Medicine. 37(3). 166–176. 26 indexed citations
5.
Hasina, Rifat, Mark Whipple, Leslie E. Martin, et al.. (2008). Angiogenic heterogeneity in head and neck squamous cell carcinoma: biological and therapeutic implications. Laboratory Investigation. 88(4). 342–353. 44 indexed citations
6.
Cohen, Ezra E.W., Mark W. Lingen, Bangmin Zhu, et al.. (2006). Protein Kinase Cζ Mediates Epidermal Growth Factor–Induced Growth of Head and Neck Tumor Cells by Regulating Mitogen-Activated Protein Kinase. Cancer Research. 66(12). 6296–6303. 63 indexed citations
7.
Cohen, Ezra E.W., Mark W. Lingen, Michael Straza, et al.. (2006). Protein kinase C Zeta mediates EGF-induced growth of head and neck tumor cells by regulating MAP kinase. Cancer Research. 66. 17–17. 1 indexed citations
8.
Seiwert, Tanguy Y., Ramasamy Jagadeeswaran, Maria Tretiakova, et al.. (2005). Inhibition of c-Met signaling by SU11274 in head and neck squamous cell carcinoma (HNSCC). Cancer Research. 65. 1405–1405. 2 indexed citations
9.
Cohen, Ezra E.W., Mark W. Lingen, Leslie E. Martin, et al.. (2005). Response of Some Head and Neck Cancers to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors May Be Linked to Mutation ofERBB2rather thanEGFR. Clinical Cancer Research. 11(22). 8105–8108. 104 indexed citations
10.
Smith, A. Ian, et al.. (1984). Ranitidine disposition and systemic availability in hepatic cirrhosis. Clinical Pharmacology & Therapeutics. 35(4). 487–494. 20 indexed citations
11.
Bradbury, A.F., et al.. (1983). The metabolism of loxtidine in rat and dog. Biochemical Society Transactions. 11(6). 715–716. 1 indexed citations
12.
Jenner, William N., et al.. (1983). Radioimmunoassay of loxtidine and lamtidine in biological fluids. Biochemical Society Transactions. 11(6). 713–714. 3 indexed citations
14.
Hillman, Laura S., Leslie E. Martin, & B. Fiore. (1981). Effect of oral copper supplementation on serum copper and ceruloplasmin concentrations in premature infants. The Journal of Pediatrics. 98(2). 311–313. 27 indexed citations
15.
Jenner, William N., et al.. (1981). The development of a radioimmunoassay for ranitidine in biological fluids. Life Sciences. 28(12). 1323–1329. 35 indexed citations
16.
Jenner, William N., et al.. (1980). The metabolism of ranitidine in animals and man. Biochemical Society Transactions. 8(1). 93–93. 28 indexed citations
17.
Hopkins, Robert, et al.. (1976). The Metabolism of Labetalol in Animals and Man. Biochemical Society Transactions. 4(4). 726–729. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026